Dr. Chad Bisambar, Endocrinologist and Diabetologist, joins Trinidad & Tobago Today to answer pressing questions about GLP-1 medications, including Ozempic and Mounjaro.
With specialist training from the University of Cambridge and over ten years of clinical experience, Dr. Bisambar explains how these drugs work, their effectiveness in diabetes management and weight loss, potential risks and side effects, and their broader health benefits.
He also addresses concerns around unregulated access in Trinidad and Tobago, the importance of proper medical oversight, and shares guidance for patients considering GLP-1 therapies.